| Literature DB >> 30940147 |
Abdulhalik Workicho1,2, Tefera Belachew3, Alemayehu Argaw3,4, Shibani Ghosh5, Meghan Kershaw5, Carl Lachat4, Patrick Kolsteren4.
Abstract
BACKGROUND: Evidences indicate that the risk of linear growth faltering is higher among children born from young mothers. Although such findings have been documented in various studies, they mainly originate from cross-sectional data and demographic and health surveys which are not designed to capture the growth trajectories of the same group of children. This study aimed to assess the association between young maternal age and linear growth of infants using data from a birth cohort study in Ethiopia.Entities:
Keywords: Adolescent pregnancy; Infant growth; Linear growth; Maternal age
Mesh:
Year: 2019 PMID: 30940147 PMCID: PMC6806577 DOI: 10.1186/s12937-019-0448-0
Source DB: PubMed Journal: Nutr J ISSN: 1475-2891 Impact factor: 3.271
Fig. 1Flow diagram of follow up of study participants
Distribution of study variables by maternal age at delivery
| Variables | Maternal age in years | ||
|---|---|---|---|
| 15–19 ( | 20–24 ( | ||
| Maternal education | |||
| no formal education | 86 (22.2) | 372 (35.9) | < 0.001* |
| primary | 273 (70.5) | 566 (54.6) | |
| secondary & above | 28 (7.2) | 98 (9.5) | |
| Wealth index | |||
| Lowest | 152 (39.3) | 377 (36.4) | 0.60 |
| Middle | 109 (28.2) | 304 (29.3) | |
| Highest | 126 (32.6) | 355 (34.3) | |
| iron-folic acid intake, (> 90 days) | 113 (29.2) | 326 (31.5) | 0.41 |
| Illness in previous 2 weeks | 223 (57.6) | 647 (62.5) | 0.09 |
| infant sex, (male) | 187 (48.3) | 517 (49.9) | 0.60 |
| Mean(±SD) length (cm) | |||
| At birth | 49.32 (2.26) | 49.53 (2.21) | |
| 3rd month | 60.52 (2.40) | 60.87 (2.62) | |
| 6th month | 65.54 (2.68) | 65.71 (2.71) | |
| 9th month | 69.12 (2.62) | 68.92 (2.69) | |
| 12th month | 72.22 (2.53) | 71.95 (2.65) | |
*statistically significant difference at p < 0.05
Fig. 2Linear growth of infants over 12 months from Mothers of 15–19 years old (---------) and Mothers of 20–24 years (______). Plotted values for the difference from baseline of the repeated measurements are estimated from linear mixed-effects model using random intercept child and random slope time with fixed effects including time, quadratic time, maternal age group, and timeXmaternal age group interactions adjusted for important covariates. The P-value is for group difference on monthly changes of LAZ score over time. β coefficient on monthly changes in LAZ was 0.05; P = 0.179
Fig. 3linear growth of infants by maternal and infant characteristics: Linear growth and maternal educational status; no formal education (____), primary (---------) and secondary and above (— — —), linear growth and iron and folic acid intake; < 90 days (--------) and ≥ 90 days (_____) and linear growth and infant illness; No (____) and Yes (-------). P-values are for group difference on monthly changes of LAZ score over time. β (95% CI) on monthly changes in LAZ were 0.03 (0.003,0.55); P = 0.024 for Maternal educational status of secondary and above, 0.02 (− 0.01,0.30); P = 0.051for primary maternal educational status, 0.15 (0.02,0.30); P = 0.018for iron-folic acid intake, − 0.15 (− 0.30, − 0.002); P = 0.001 for infant illness
Parameter estimates from linear mixed effects model predicting linear growth of infants
| Fixed effects ( | Coefficient (β) | SE |
|
|---|---|---|---|
| Intercept | 1.38 | 0.143 | < 0.001* |
| Infant age (Time) | 0.14 | 0.029 | < 0.001* |
| Quadratic time effect (Time*Time) | −0.01 | 0.002 | < 0.001* |
| Maternal age (15–19 years) | − 0.24 | 0.128 | 0.032 |
| Maternal age*Time | 0.05 | 0.034 | 0.179 |
| LAZ at birth | 0.38 | 0.029 | < 0.001* |
Maternal education (ref = no formal education) | |||
| Primary | 0.05 | 0.077 | 0.518 |
| Primary*Time | 0.02 | 0.007 | 0.051 |
| ≥ Secondary | 0.10 | 0.135 | 0.417 |
| ≥ Secondary*Time | 0.03 | 0.013 | 0.024 |
| Wealth index (ref = low) | |||
| Middle | 0.21 | 0.084 | 0.004* |
| Middle*Time | −0.05 | 0.008 | 0.485 |
| High | 0.13 | 0.084 | 0.018 |
| High*Time | 0.01 | 0.008 | 0.245 |
| Iron-folate supplement (≥90 days) | −0.07 | 0.074 | 0.305 |
| Iron-folate*Time | 0.15 | 0.007 | 0.018 |
| Illness in 2 weeks (Yes) | 0.05 | 0.070 | 0.495 |
| Illness in 2 weeks *Time | −0.15 | 0.006 | 0.001* |
| Random effects | |||
| Variance of random intercept | 0.004 | 0.006 | |
| Variance of random slope | 0.913 | 0.063 | |
| Covariance of random intercept and slope | −0.033 | 0.005 | |
| Variance of residuals | 0.402 | 0.011 | |
Restricted maximum likelihood estimation (REML) was used to estimate the parameters, SE standard error, *Statistical significance after adjustment for multiple testing using Benjamini-Hochberg method